Healthcare -
Biotechnology - NASDAQ - US
$ 8.885
-1.39 %
$ 1.42 B
Market Cap
-4.08
P/E
NVAX - CAPITAL EXPENDITURES
Capital Expenditures NVAX - Novavax, Inc.
-58.8 M
LAST VALUE
-1.14%
2 YEAR CAGR
-112.04%
5 YEAR CAGR
-26.10%
10 YEAR CAGR